How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19
source: pixabay.com

How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19

From social distancing and shuttered businesses to personal health concerns, COVID-19 has changed daily life for the foreseeable future. There are nearly 4.75 million diagnoses worldwide, with 1.53 million in…

Continue Reading How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19
Gilead Donates 940,000 Remdesivir Doses
Photo by Paweł Czerwiński on Unsplash

Gilead Donates 940,000 Remdesivir Doses

Multiple biotechnology and pharmaceutical companies have joined in the fight against COVID-19. But one, Gilead Sciences, has been at the forefront of both progress and controversy. The company developed remdesivir,…

Continue Reading Gilead Donates 940,000 Remdesivir Doses
A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Photo by National Cancer Institute on Unsplash

A Negative Side Effect of COVID-19: Reduced Cancer Screenings

In her early 20's, Mackenzie Alleman lost her mother to breast cancer. Then, at 28, she herself underwent a preventative double mastectomy after learning that she carried the mutated BRCA1 gene.…

Continue Reading A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
source: pixabay.com

Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic

By Natalie Homan from In The Cloud Copy Two businesses that advocate for patients with rare and orphan diseases announced recently that they are teaming up to help patients get…

Continue Reading Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
source: pixabay.com

New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients

  New information, speculation, statistics, and predictions about COVID-19 are hitting the internet every day. Yet neurologists are attempting to answer their patients’ questions without having sufficient data that would…

Continue Reading New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil
source: pixabay.com

COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil

  A recent article in Biospace reported an 83% survival rate for COVID-19 patients after two infusions of the experimental drug Ryoncil, developed by Mesoblast Ltd. The patients who were…

Continue Reading COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil